These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32546033)

  • 21. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum proNGF concentration in patients with Parkinson's disease.
    Xu XM; Dong MX; Feng X; Liu Y; Pan JX; Jia SY; Cao D; Wei YD
    Neurol Sci; 2018 Jan; 39(1):91-96. PubMed ID: 29052090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA Expression Profile Changes in the Leukocytes of Parkinson's Disease Patients.
    Ardashirova NS; Abramycheva NY; Fedotova EY; Illarioshkin SN
    Acta Naturae; 2022; 14(3):79-84. PubMed ID: 36348717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
    Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
    Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease.
    Han L; Tang Y; Bai X; Liang X; Fan Y; Shen Y; Huang F; Wang J
    Aging (Albany NY); 2020 Jul; 12(13):13518-13528. PubMed ID: 32649312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J; Chen C; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
    Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of gut miRNAs in idiopathic Parkinson's disease.
    Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T
    Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
    Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
    Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression.
    Jin L; Wan W; Wang L; Wang C; Xiao J; Zhang F; Zhao J; Wang J; Zhan C; Zhong C
    Neurosci Lett; 2018 Nov; 687():88-93. PubMed ID: 30243884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.
    Zhao N; Jin L; Fei G; Zheng Z; Zhong C
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1177-80. PubMed ID: 25218846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China.
    Zhu Y; Zhu X; Zhou Y; Zhang D
    Neurol Sci; 2021 May; 42(5):1835-1841. PubMed ID: 32909152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.